Literature DB >> 6480011

Self-poisoning with dextropropoxyphene and dextropropoxyphene compounds: the USA experience.

B S Finkle.   

Abstract

This survey continues and expands earlier studies (Finkle et al., 1976a, b). A total of 27 medical examiner or coroner offices across the USA and Canada were visited. The combined jurisdictional population of these 27 sites is 64.8 million people: 56.5 million people in the USA (27% of the US population) and 8.3 million in Canada (Ontario). Since 1969 through mid-1983, a total of 4412 cases provided information sufficient for inclusion in this study. In each of the cases the presence of propoxyphene, and often its major metabolite, in the blood or tissues of the deceased was confirmed by toxicological analysis at the survey site. The following is a summary of the survey findings: The incidence of propoxyphene-associated deaths reached a peak in 1977, then declined by 22.2% from 1977 to 1978 and by 33.3% from 1978 to 1979, and by a further 10-18% since then. This continuing decline has occurred despite increased interest in propoxyphene misuse and the existence of improved analytical methods for the detection of propoxyphene and its metabolites. The decline is greater than can be accounted for by the decline in propoxyphene prescribing. The most common manner of death was suicide, accounting for about 45% of the cases; it can be safely assumed that the suicides were under-reported. A large majority of the suicides involving propoxyphene were multiple-drug intoxications, including alcohol. Propoxyphene alone was noted in about one-sixth of the suicides. These findings confirm those of the earlier studies, i.e., that a high proportion of the deaths associated with propoxyphene are suicides, and, in most cases, the deceased were victims of multiple-drug toxicity. More than 90% of cases involved persons between the ages of 20 and 40 years. There were very few instances of paediatric, adolescent or older adult deaths associated with propoxyphene. There is no evidence to support the view that the deceased were part of the street drug-abuse population. A history of heroin abuse appeared in less than 5% of the cases. Even fewer people had been known to have abused propoxyphene before their deaths, but 18% of the population had been known to 'self-medicate', using multiple drugs without appropriate medical supervision. The distribution of males to females approximated that of the US population.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6480011     DOI: 10.1177/096032718400300113

Source DB:  PubMed          Journal:  Hum Toxicol        ISSN: 0144-5952


  10 in total

Review 1.  Dextropropoxyphene: safety and efficacy in older patients.

Authors:  David J Goldstein; Dennis C Turk
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

Review 2.  Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.

Authors:  A A Lawson; D B Northridge
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Nov-Dec

3.  A multicentre study of coproxamol poisoning suicides based on coroners' records in England.

Authors:  K Hawton; S Simkin; D Gunnell; L Sutton; O Bennewith; P Turnbull; N Kapur
Journal:  Br J Clin Pharmacol       Date:  2005-02       Impact factor: 4.335

4.  Marked QRS complex abnormalities and sodium channel blockade by propoxyphene reversed with lidocaine.

Authors:  D C Whitcomb; F R Gilliam; C F Starmer; A O Grant
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

5.  Effect of government and commercial warnings on reducing prescription misuse: the case of propoxyphene.

Authors:  S B Soumerai; J Avorn; S Gortmaker; S Hawley
Journal:  Am J Public Health       Date:  1987-12       Impact factor: 9.308

6.  Dextropropoxyphene-related deaths--a problem that persists?

Authors:  J O Obafunwa; A Busuttil; A M al-Oqleh
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

7.  [Sustained-release dextropropoxyphene.].

Authors:  K Kurz-Müller; M Zenz
Journal:  Schmerz       Date:  1991-12       Impact factor: 1.107

8.  Ban on Dextropropoxyphene is Unjustifiable.

Authors:  Savita Butola; Mr Rajagopal
Journal:  Indian J Palliat Care       Date:  2015 Jan-Apr

9.  Effect of withdrawal of co-proxamol on prescribing and deaths from drug poisoning in England and Wales: time series analysis.

Authors:  Keith Hawton; Helen Bergen; Sue Simkin; Anita Brock; Clare Griffiths; Ester Romeri; Karen L Smith; Navneet Kapur; David Gunnell
Journal:  BMJ       Date:  2009-06-18

10.  Dextropropoxyphene ban in India: Is there a case for reconsideration?

Authors:  Yatan Pal Singh Balhara
Journal:  J Pharmacol Pharmacother       Date:  2014-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.